 James Goodrich
Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 29 | 2021 | 285 | 4.790 |
Why?
| | Transcription, Genetic | 36 | 2021 | 1317 | 4.330 |
Why?
| | RNA, Untranslated | 14 | 2016 | 113 | 3.630 |
Why?
| | Promoter Regions, Genetic | 25 | 2021 | 1133 | 2.280 |
Why?
| | DNA | 19 | 2023 | 1351 | 1.540 |
Why?
| | Proto-Oncogene Proteins c-jun | 4 | 2014 | 47 | 1.130 |
Why?
| | Gene Expression Regulation | 10 | 2020 | 2324 | 1.110 |
Why?
| | Interleukin-2 | 5 | 2014 | 419 | 1.050 |
Why?
| | Short Interspersed Nucleotide Elements | 4 | 2010 | 10 | 1.050 |
Why?
| | RNA, Messenger | 11 | 2020 | 2559 | 1.010 |
Why?
| | Nucleic Acid Conformation | 14 | 2020 | 669 | 0.950 |
Why?
| | Alu Elements | 4 | 2014 | 26 | 0.920 |
Why?
| | TATA Box | 5 | 2017 | 22 | 0.850 |
Why?
| | TATA-Box Binding Protein | 5 | 2013 | 19 | 0.850 |
Why?
| | Protein Binding | 17 | 2023 | 1897 | 0.770 |
Why?
| | NFATC Transcription Factors | 2 | 2013 | 78 | 0.760 |
Why?
| | Response Elements | 2 | 2023 | 83 | 0.760 |
Why?
| | RNA | 8 | 2023 | 810 | 0.740 |
Why?
| | Heat-Shock Response | 4 | 2018 | 46 | 0.730 |
Why?
| | Single Molecule Imaging | 3 | 2020 | 29 | 0.730 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2023 | 447 | 0.720 |
Why?
| | Transcriptional Activation | 4 | 2013 | 337 | 0.680 |
Why?
| | Herpesvirus 1, Human | 2 | 2021 | 76 | 0.660 |
Why?
| | Transcription Factor TFIIB | 4 | 2020 | 13 | 0.660 |
Why?
| | TATA-Binding Protein Associated Factors | 3 | 2010 | 15 | 0.650 |
Why?
| | Transcription Factors, TFII | 6 | 2016 | 37 | 0.640 |
Why?
| | DNA-Binding Proteins | 5 | 2023 | 1317 | 0.620 |
Why?
| | Transcription Initiation Site | 2 | 2017 | 40 | 0.570 |
Why?
| | Base Sequence | 10 | 2017 | 2118 | 0.550 |
Why?
| | Transcription Factors, General | 1 | 2016 | 5 | 0.540 |
Why?
| | Transcription Initiation, Genetic | 1 | 2016 | 11 | 0.530 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2015 | 73 | 0.480 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 398 | 0.470 |
Why?
| | Mammals | 1 | 2016 | 245 | 0.460 |
Why?
| | Virus Replication | 1 | 2015 | 395 | 0.440 |
Why?
| | Binding Sites | 7 | 2020 | 1176 | 0.430 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 296 | 0.420 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 20 | 0.420 |
Why?
| | Chromatin | 7 | 2023 | 428 | 0.420 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 88 | 0.400 |
Why?
| | RNA Stability | 1 | 2013 | 90 | 0.400 |
Why?
| | Gene Silencing | 2 | 2010 | 172 | 0.400 |
Why?
| | Cell Cycle | 1 | 2014 | 544 | 0.370 |
Why?
| | Models, Genetic | 7 | 2018 | 565 | 0.370 |
Why?
| | Models, Biological | 10 | 2013 | 1630 | 0.370 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 154 | 0.360 |
Why?
| | Kinetics | 8 | 2020 | 1555 | 0.360 |
Why?
| | Proto-Oncogene Proteins c-fos | 4 | 2014 | 164 | 0.350 |
Why?
| | Genome | 2 | 2010 | 272 | 0.350 |
Why?
| | Animals | 21 | 2020 | 31839 | 0.340 |
Why?
| | Protein Structure, Tertiary | 2 | 2010 | 797 | 0.340 |
Why?
| | Eukaryota | 1 | 2010 | 47 | 0.340 |
Why?
| | Humans | 41 | 2023 | 114937 | 0.340 |
Why?
| | RNA Polymerase III | 1 | 2009 | 25 | 0.330 |
Why?
| | RNA, Small Nuclear | 1 | 2009 | 31 | 0.330 |
Why?
| | HMGB1 Protein | 2 | 2021 | 48 | 0.320 |
Why?
| | Transcription Factor TFIIA | 2 | 2010 | 8 | 0.320 |
Why?
| | Transcription Factor TFIID | 2 | 2010 | 21 | 0.310 |
Why?
| | Fluorescence Resonance Energy Transfer | 5 | 2016 | 169 | 0.310 |
Why?
| | Molecular Sequence Data | 7 | 2013 | 2791 | 0.290 |
Why?
| | Transcription Factors | 3 | 2016 | 1530 | 0.280 |
Why?
| | Cell Proliferation | 1 | 2014 | 2199 | 0.270 |
Why?
| | Micrococcal Nuclease | 1 | 2006 | 19 | 0.260 |
Why?
| | Protein Interaction Mapping | 1 | 2006 | 101 | 0.250 |
Why?
| | Templates, Genetic | 4 | 2016 | 59 | 0.250 |
Why?
| | Nucleic Acids | 1 | 2006 | 59 | 0.250 |
Why?
| | Mice | 12 | 2020 | 14936 | 0.240 |
Why?
| | Catalytic Domain | 3 | 2013 | 197 | 0.220 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 80 | 0.220 |
Why?
| | Trans-Activators | 1 | 2006 | 368 | 0.220 |
Why?
| | Polynucleotides | 1 | 2023 | 13 | 0.220 |
Why?
| | Transcription Factor TFIIH | 3 | 2011 | 34 | 0.210 |
Why?
| | Biochemistry | 1 | 2003 | 40 | 0.210 |
Why?
| | Oligoribonucleotides | 1 | 2002 | 52 | 0.200 |
Why?
| | HMGB2 Protein | 1 | 2021 | 4 | 0.200 |
Why?
| | Cell Line | 4 | 2023 | 2640 | 0.190 |
Why?
| | Jurkat Cells | 2 | 2013 | 128 | 0.190 |
Why?
| | HMGB Proteins | 1 | 2021 | 15 | 0.190 |
Why?
| | Immediate-Early Proteins | 1 | 2021 | 52 | 0.190 |
Why?
| | Recombinant Proteins | 3 | 2010 | 1233 | 0.190 |
Why?
| | Tumor Suppressor Proteins | 1 | 2023 | 282 | 0.190 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2018 | 129 | 0.190 |
Why?
| | Herpes Simplex | 1 | 2021 | 87 | 0.180 |
Why?
| | NIH 3T3 Cells | 4 | 2018 | 137 | 0.180 |
Why?
| | Models, Molecular | 2 | 2020 | 1379 | 0.180 |
Why?
| | Aptamers, Nucleotide | 2 | 2014 | 73 | 0.170 |
Why?
| | Proteins | 1 | 2006 | 912 | 0.170 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 99 | 0.170 |
Why?
| | HeLa Cells | 2 | 2013 | 562 | 0.170 |
Why?
| | Muscle Development | 1 | 2020 | 98 | 0.170 |
Why?
| | Ethanol | 1 | 2023 | 548 | 0.160 |
Why?
| | Transcription Termination, Genetic | 1 | 2018 | 12 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 3 | 2006 | 617 | 0.150 |
Why?
| | RNA Interference | 1 | 2020 | 437 | 0.150 |
Why?
| | Nucleosomes | 3 | 2021 | 122 | 0.150 |
Why?
| | Consensus Sequence | 1 | 2017 | 70 | 0.140 |
Why?
| | Fluorescent Dyes | 2 | 2016 | 300 | 0.140 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2020 | 441 | 0.140 |
Why?
| | Enzyme Assays | 1 | 2016 | 21 | 0.130 |
Why?
| | Enzymes, Immobilized | 1 | 2016 | 25 | 0.130 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2009 | 51 | 0.130 |
Why?
| | Protein Stability | 1 | 2016 | 157 | 0.130 |
Why?
| | Protein Multimerization | 2 | 2014 | 159 | 0.130 |
Why?
| | Glutathione Transferase | 2 | 2006 | 94 | 0.120 |
Why?
| | Dimerization | 2 | 2006 | 176 | 0.120 |
Why?
| | Binding, Competitive | 1 | 2015 | 194 | 0.120 |
Why?
| | Mutation | 3 | 2013 | 3354 | 0.120 |
Why?
| | Thermodynamics | 2 | 2007 | 383 | 0.120 |
Why?
| | MicroRNAs | 1 | 2020 | 601 | 0.110 |
Why?
| | In Vitro Techniques | 3 | 2005 | 1034 | 0.110 |
Why?
| | Phosphorylation | 3 | 2014 | 1572 | 0.110 |
Why?
| | Plasmids | 2 | 2004 | 345 | 0.110 |
Why?
| | DNA Cleavage | 1 | 2013 | 6 | 0.110 |
Why?
| | Luciferases | 1 | 2013 | 142 | 0.110 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 729 | 0.110 |
Why?
| | Breast Neoplasms | 1 | 2023 | 1870 | 0.100 |
Why?
| | Time Factors | 3 | 2009 | 6125 | 0.100 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2004 | 1856 | 0.100 |
Why?
| | Transfection | 1 | 2013 | 870 | 0.090 |
Why?
| | Down-Regulation | 2 | 2010 | 596 | 0.090 |
Why?
| | Oligonucleotides, Antisense | 2 | 2008 | 100 | 0.090 |
Why?
| | Yeasts | 1 | 2010 | 49 | 0.090 |
Why?
| | Germ Cells | 1 | 2010 | 57 | 0.090 |
Why?
| | Hot Temperature | 3 | 2011 | 304 | 0.090 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2010 | 132 | 0.080 |
Why?
| | Embryonic Development | 1 | 2010 | 117 | 0.080 |
Why?
| | Esterification | 1 | 2009 | 12 | 0.080 |
Why?
| | DNA Primers | 1 | 2010 | 514 | 0.080 |
Why?
| | Cell Differentiation | 2 | 2020 | 1699 | 0.080 |
Why?
| | Genomic Imprinting | 1 | 2009 | 32 | 0.080 |
Why?
| | Gene Regulatory Networks | 1 | 2010 | 228 | 0.080 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 191 | 0.080 |
Why?
| | Protein Conformation | 2 | 2013 | 811 | 0.080 |
Why?
| | RNA, Bacterial | 1 | 2009 | 174 | 0.070 |
Why?
| | Sequence Analysis | 1 | 2007 | 35 | 0.070 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2006 | 8 | 0.070 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 17 | 0.070 |
Why?
| | Centrifugation | 1 | 2006 | 31 | 0.070 |
Why?
| | Sepharose | 1 | 2006 | 31 | 0.070 |
Why?
| | Chromatography, Affinity | 1 | 2006 | 81 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2007 | 152 | 0.070 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 319 | 0.060 |
Why?
| | Adenoviridae | 1 | 2005 | 185 | 0.060 |
Why?
| | Cell Nucleus | 2 | 2004 | 554 | 0.060 |
Why?
| | Leucine Zippers | 1 | 2004 | 16 | 0.060 |
Why?
| | Glutathione | 1 | 2006 | 300 | 0.060 |
Why?
| | Salts | 1 | 2004 | 36 | 0.060 |
Why?
| | COS Cells | 1 | 2004 | 175 | 0.060 |
Why?
| | Histone Acetyltransferases | 1 | 2004 | 51 | 0.060 |
Why?
| | Amino Acid Sequence | 2 | 2004 | 1988 | 0.050 |
Why?
| | Breast | 1 | 2023 | 141 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1749 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2002 | 54 | 0.050 |
Why?
| | Peptides | 2 | 2004 | 848 | 0.050 |
Why?
| | Models, Chemical | 1 | 2003 | 250 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2002 | 118 | 0.050 |
Why?
| | Histone Deacetylases | 1 | 2002 | 196 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2023 | 344 | 0.040 |
Why?
| | Fluorescence | 1 | 2020 | 148 | 0.040 |
Why?
| | Genome, Human | 1 | 2021 | 352 | 0.040 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 129 | 0.040 |
Why?
| | Myoblasts | 1 | 2020 | 76 | 0.040 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 78 | 0.040 |
Why?
| | HEK293 Cells | 1 | 2021 | 593 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2002 | 368 | 0.040 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2018 | 7 | 0.040 |
Why?
| | DNA Footprinting | 2 | 2010 | 28 | 0.040 |
Why?
| | Optical Imaging | 1 | 2019 | 54 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 576 | 0.040 |
Why?
| | Protein Domains | 1 | 2016 | 207 | 0.030 |
Why?
| | SELEX Aptamer Technique | 1 | 2014 | 14 | 0.030 |
Why?
| | Optical Tweezers | 1 | 2014 | 18 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2014 | 257 | 0.030 |
Why?
| | Epigenetic Repression | 1 | 2013 | 3 | 0.030 |
Why?
| | Buffers | 1 | 2013 | 53 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 2013 | 490 | 0.020 |
Why?
| | Cyclin H | 1 | 2011 | 2 | 0.020 |
Why?
| | Female | 2 | 2023 | 59581 | 0.020 |
Why?
| | Serine | 1 | 2011 | 126 | 0.020 |
Why?
| | Isomerism | 1 | 2010 | 43 | 0.020 |
Why?
| | Deoxyribonuclease I | 1 | 2010 | 35 | 0.020 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2011 | 111 | 0.020 |
Why?
| | Saccharomyces cerevisiae | 1 | 2013 | 477 | 0.020 |
Why?
| | Protein Kinases | 1 | 2011 | 307 | 0.020 |
Why?
| | Actins | 1 | 2011 | 382 | 0.020 |
Why?
| | Blotting, Western | 1 | 2011 | 1151 | 0.020 |
Why?
| | Sequence Deletion | 1 | 2007 | 168 | 0.020 |
Why?
| | Algorithms | 1 | 2013 | 1474 | 0.020 |
Why?
| | Male | 1 | 2010 | 55663 | 0.020 |
Why?
| | Precipitin Tests | 1 | 2004 | 88 | 0.010 |
Why?
| | Okadaic Acid | 1 | 2002 | 11 | 0.010 |
Why?
| | Histone Deacetylase 2 | 1 | 2002 | 7 | 0.010 |
Why?
| | Nocodazole | 1 | 2002 | 17 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 929 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 78 | 0.010 |
Why?
| | K562 Cells | 1 | 2002 | 73 | 0.010 |
Why?
| | Catalysis | 1 | 2002 | 292 | 0.010 |
Why?
| | Mitosis | 1 | 2002 | 164 | 0.010 |
Why?
| | Paclitaxel | 1 | 2002 | 190 | 0.010 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2002 | 181 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2002 | 752 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2002 | 1635 | 0.010 |
Why?
| | Histones | 1 | 2002 | 536 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2002 | 1897 | 0.010 |
Why?
| | Signal Transduction | 1 | 2002 | 4525 | 0.010 |
Why?
|
|
Goodrich's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|